Biden's Move To Release More Vaccine Doses Comes With Some Risks : Shots
Experts argue that pushing out more COVID-19 vaccine doses to states sooner may be a good idea, even if it means there's a chance some people's second dose gets delayed.
Stay updated with breaking news from Immunization Managers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts argue that pushing out more COVID-19 vaccine doses to states sooner may be a good idea, even if it means there's a chance some people's second dose gets delayed.
By Sabrina Siddiqui and Stephanie Armour WASHINGTON -- President-elect Joe Biden will seek to release nearly all available coronavirus vaccine doses to accelerate distribution, his transition team said Friday, in a shift from the Trump administration's policy of holding back stock for second doses. "The president-elect believes we must accelerate distribution of the vaccine while continuing to ensure the Americans who need it most get it as soon as possible," said TJ Ducklo, a spokesman for Mr. Biden's transition. "He supports releasing available doses immediately, and believes th...
3 months old This article is more than 3 months old Scant funding and scattered logistics have slowed distribution process as coronavirus case numbers rise, painting a dire picture for the future Healthcare workers treat coronavirus patients at United Memorial Medical Center in Houston, Texas on 31 December 2020. Photograph: Callaghan O’Hare/Reuters Healthcare workers treat coronavirus patients at United Memorial Medical Center in Houston, Texas on 31 December 2020. Photograph: Callaghan O’Hare/Reuters Victoria Bekiempis in New York and agencies Sat 2 Jan 2021 02.00 EST Last modified on...
Reuters Reuters 1 January, 2021, 2:08 pm FILE PHOTO: George Valley, a patient at Crown Heights Center for Nursing and Rehabilitation, a nursing home facility, receives the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from Walgreens Pharmacist Annette Marshall, in Brooklyn, New York, U.S., December 22, 2020. REUTERS/Yuki Iwamura/File Photo NEW YORK (Reuters) -Seattle public health officials have so little COVID-19 funding on hand they worry they will have to shut down some virus testing sites as they mount a campaign to dose their 2.3 million residents with Pfizer Inc’s and Moderna...
Vaccine rollout falls short of expectations, raising questions about 2021 timeline © Brendan Smialowski/AFP via Getty Images A pharmacist dilutes the Pfizer COVID-19 vaccine while preparing it to administer to staff and residents at the Goodwin House Bailey's Crossroads, a senior living community in Falls Church, Va., Dec. 30, 2020. The U.S. COVID-19 vaccine rollout moved slower than expected this month, stoking fears that the federal government was mishandling the effort and that people would have to wait months longer than expected to get their shot. Federal officials defended the pro...